Cogitum (Cogitum)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceAcetylaminosuccinic acidAcetylaminosuccinic acid
Similar drugsTo uncover
  • Cogitum
    solution inwards 
    SANOFI RUSSIA, CJSC    
    • Dosage form: & nbsporal solution
    Composition:

    10 ml of solution contains:

    active substance: potassium acetylamino succinate 250 mg;

    Excipients: fructose 1000 mg, methyl parahydroxybenzoate 15 mg, banana flavor 7 mg, water purified to 10 ml.
    Description:Transparent light yellow solution with the smell of a banana.
    Pharmacotherapeutic group:Common Toning Agent
    ATX: & nbsp

    N.06.B.X   Other psychostimulants and nootropic drugs

    Pharmacodynamics:

    The effective start of the drug is acetylamino succinic acid - biologically active compound contained in the central nervous system of the central nervous system. The drug contributes to the normalization of the processes of nervous regulation, has a stimulating effect.

    Indications:As part of the complex therapy of asthenic syndrome.
    Contraindications:

    Hypersensitivity reactions to acetylaminosuccinic acid or any of the components of the drug.

    Children under 7 years old (no clinical data available).

    Pregnancy (lack of clinical data).

    Pregnancy and lactation:

    Pregnancy

    The use in pregnancy is contraindicated (due to insufficient data).

    Women in the period of breastfeeding

    For the duration of treatment with the drug, breastfeeding should be discontinued.

    Dosing and Administration:

    The drug is intended for oral administration. The dose is prescribed individually by the doctor. The average dose for adults is 3 ampoules a day: 2 - in the morning and 1 - at night. The maximum dose is not known.

    Children aged 7 to 10 years are recommended ingestion of 1 ampoule in the morning, in children aged 10 to 18 years, it is recommended to take 2 ampoules in the morning.

    For reception it is necessary to open the ampoule from one side, then, having substituted a glass or a cup under the opened end, break off the opposite end of the ampoule. After that, the liquid will freely flow into the substituted container. The taste qualities of the preparation allow using it without prior dilution. If it is diluted with water, a loss of banana taste is possible. Most preferable is the morning intake of the drug.

    The average duration of treatment in children and adults is 3 weeks.

    If, for any reason, one or more doses of the drug were missed, the treatment can be continued without the need for a secondary dose adjustment.

    Treatment can also be suddenly discontinued without any serious consequences for the patient.

    Side effects:

    Allergic reactions are possible.

    Overdose:

    To date, there have been no reports of overdose of Coguitum. No toxic effects are expected.

    Interaction:

    No interaction with other drugs was noted.

    Special instructions:

    Children and teens

    See "Dosage regimen and method of use".

    Elderly patients

    The drug can be used in elderly patients.

    Effect on the ability to drive transp. cf. and fur:

    No data.

    It is unlikely that the drug may affect the ability to drive vehicles, mechanisms or to engage in other potentially hazardous activities.

    Form release / dosage:Solution for oral administration 25 mg / ml.
    Packaging:

    For 10 ml of the drug in a dark glass ampoule (type III), sealed on both sides, with a fault line and applying a marking ring to each side. 10 ampoules per packing insert made of cardboard. By 3 packing inserts from a cardboard together with the instruction on application in a cardboard pack.

    Storage conditions:

    In the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children!

    Shelf life:

    3 years.After the expiration date, the drug should not be used.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N011377 / 01
    Date of registration:02.08.2011 / 13.03.2017
    Expiration Date:Unlimited
    The owner of the registration certificate:SANOFI RUSSIA, CJSCSANOFI RUSSIA, CJSC
    Manufacturer: & nbsp
    Representation: & nbspSanofi Aventis GroupSanofi Aventis Group
    Information update date: & nbsp30.01.2018
    Illustrated instructions
      Instructions
      Up